Comparison of In Vitro Ibuprofen Release Rates from HPMC and Carbopol® Gels

Year 2024, Volume: 7 Issue: 2, 40 - 47, 28.11.2024

Emine Dilek Özyılmaz , Açelya Mavideniz , Zahra Nobavar

https://doi.org/10.54994/emujpharmsci.1530626

Abstract

Topical drug delivery systems have become a critical area of research because of their ability to deliver active pharmaceutical ingredients directly to the target site, thereby reducing systemic exposure and associated side effects. Non-steroidal anti-inflammatory drugs like ibuprofen are frequently used in these systems for their strong pain-relieving and anti-inflammatory properties. In the present study, an HPMC gel formulation containing the same amount of ibuprofen (5% w/w) was prepared as an alternative to the market formulation, which is prepared with Carbopol 934® as the gelling agent. The aim was to compare the two formulations in terms of the release rate of the active substance. The study results demonstrated that the HPMC gel containing ibuprofen, formulated as an alternative to the market formulation, meets pharmaceutical criteria in terms of pH, viscosity, appearance, and active ingredient content (90-105%). Furthermore, the release rate of ibuprofen from gel was statistically significantly different compared to the market formulation prepared with Carbopol 934® (p<0.05). Based on the findings, it can be concluded that the prepared gel formulation may serve as an alternative to the market formulation containing the same amount of active ingredient. This is particularly desirable for enhancing the onset of anti-inflammatory and analgesic effects by increasing the release rate.

Keywords

Carbopol®, HPMC, ibuprofen, release rate, physicochemical controls

References

• Ardana M, Aeyni V, Ibrahim A (2015). Formulasi dan optimasi basis gel HPMC (hidroxy propyl methyl cellulose) dengan berbagai variasi konsentrasi. J Trop Pharm Chem 3(2): 101-108.
• Boshrouyeh R, Amari S, Boshrouyeh Ghandashtani M, Alavi SE, Ebrahimi Shahmabadi H (2023). A topical gel nanoformulation of amphotericin B (AmB) for the treatment of cutaneous leishmaniasis (CL). JSST 105(3): 768-80.
• Hasnain MS, Rishishwar P, Ali S, Alkahtani S, Tabish M, et al. (2020). Formulation and ex vivo skin permeation of lidocaine HCl topical gels using dillenia (Dillenia indica L.) fruit gum. Rev Mex Ing Quim 19(3): 1465-76.
• Hundscheid T, Onland W, Kooi EM, Vijlbrief DC, de Vries WB, et al. (2023). Expectant management or early ibuprofen for patent ductus arteriosus. NEJM 388(11): 980-90.
• Kashyap A, Das A, Ahmed AB (2020). Formulation and evaluation of transdermal topical gel of ibuprofen. JDDT 10(2): 20-5.
• Mahmoud RA, Hussein AK, Nasef GA, Mansour HF (2020). Oxiconazole nitrate solid lipid nanoparticles: formulation, in-vitro characterization and clinical assessment of an analogous loaded carbopol gel. Drug Dev Ind Pharm 46(5): 706-716.
• Mancini G, Gonçalves LM, Marto J, Carvalho FA, Simões S, et al. (2021). Increased therapeutic efficacy of SLN containing etofenamate and ibuprofen in topical treatment of inflammation. Pharmaceutics 13(3): 328.
• Montes L, Rosell CM, Moreira R (2022). Rheological properties of corn starch gels with the addition of hydroxypropyl methylcellulose of different viscosities. Front nutr 9: 866789.
• Nogami S, Uchiyama H, Kadota K, Tozuka Y (2021). Design of a pH-responsive oral gel formulation based on the matrix systems of gelatin/hydroxypropyl methylcellulose phthalate for controlled drug release. Int J Pharm 592: 120047.
• Oba SN, Ighalo JO, Aniagor CO, Igwegbe CA (2021). Removal of ibuprofen from aqueous media by adsorption: A comprehensive review. Sci Total Environ 780: 146608.
• Pradal J (2020). Comparison of skin permeation and putative anti-inflammatory activity of commercially available topical products containing ibuprofen and diclofenac. J Pain Res 2020(13): 2805-2814.
• Rahmani SIP, Zulkarnain AK (2023). Optimization of HPMC and Na-CMC as gelling agents on physical properties and stability in sunflower seed oil gel formulation. J Food Pharm Sci 11(2): 812-819.
• Sung SI, Lee MH, Ahn SY, Chang YS, Park WS (2020). Effect of nonintervention vs oral ibuprofen in patent ductus arteriosus in preterm infants: a randomized clinical trial. JAMA Pediatr 174(8): 755-63.
• Theochari I, Mitsou E, Nikolic I, Ilic T, Dobricic V, et al. (2021). Colloidal nanodispersions for the topical delivery of Ibuprofen: Structure, dynamics and bioperformances. J Mol Liq 334 (2021): 116021.
• USP 32 (United States Pharmacopeia 32). United States Pharmacopeial Convention. Rockville: United States Pharmacopeial Convention; 2009.